ES2134608T3 - Agentes antimicrobianos topicos. - Google Patents

Agentes antimicrobianos topicos.

Info

Publication number
ES2134608T3
ES2134608T3 ES96909781T ES96909781T ES2134608T3 ES 2134608 T3 ES2134608 T3 ES 2134608T3 ES 96909781 T ES96909781 T ES 96909781T ES 96909781 T ES96909781 T ES 96909781T ES 2134608 T3 ES2134608 T3 ES 2134608T3
Authority
ES
Spain
Prior art keywords
antimicrobial agents
topical antimicrobial
microbial growth
topical
suffering
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES96909781T
Other languages
English (en)
Inventor
William F Wood
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Research Corp Technologies Inc
Original Assignee
Research Corp Technologies Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Research Corp Technologies Inc filed Critical Research Corp Technologies Inc
Application granted granted Critical
Publication of ES2134608T3 publication Critical patent/ES2134608T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
    • A61Q17/005—Antimicrobial preparations
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N35/00—Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a carbon atom having two bonds to hetero atoms with at the most one bond to halogen, e.g. aldehyde radical
    • A01N35/02—Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a carbon atom having two bonds to hetero atoms with at the most one bond to halogen, e.g. aldehyde radical containing aliphatically bound aldehyde or keto groups, or thio analogues thereof; Derivatives thereof, e.g. acetals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/12—Ketones
    • A61K31/121—Ketones acyclic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/35—Ketones, e.g. benzophenone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/10—Anti-acne agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C49/00—Ketones; Ketenes; Dimeric ketenes; Ketonic chelates
    • C07C49/20—Unsaturated compounds containing keto groups bound to acyclic carbon atoms
    • C07C49/203—Unsaturated compounds containing keto groups bound to acyclic carbon atoms with only carbon-to-carbon double bonds as unsaturation

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Wood Science & Technology (AREA)
  • Emergency Medicine (AREA)
  • Agronomy & Crop Science (AREA)
  • Plant Pathology (AREA)
  • Dentistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Environmental Sciences (AREA)
  • Birds (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Cosmetics (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

SE DESCRIBE UN PROCEDIMIENTO PARA INHIBIR EL CRECIMIENTO MICROBIANO, QUE INCLUYE ADMINISTRAR POR VIA TOPICA A UN MAMIFERO QUE PADECE UNA PATOLOGIA ASOCIADA CON EL CRECIMIENTO MICROBIANO, TAL COMO UN TRASTORNO DERMATOLOGICO, UNA CANTIDAD EFICAZ DE UNA 3 UB,12} C{SUB,22} LINEAL.
ES96909781T 1995-03-22 1996-03-19 Agentes antimicrobianos topicos. Expired - Lifetime ES2134608T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US08/408,913 US5604262A (en) 1995-03-22 1995-03-22 Topical antimicrobial agents

Publications (1)

Publication Number Publication Date
ES2134608T3 true ES2134608T3 (es) 1999-10-01

Family

ID=23618290

Family Applications (1)

Application Number Title Priority Date Filing Date
ES96909781T Expired - Lifetime ES2134608T3 (es) 1995-03-22 1996-03-19 Agentes antimicrobianos topicos.

Country Status (10)

Country Link
US (2) US5604262A (es)
EP (1) EP0814660B1 (es)
JP (1) JP3055701B2 (es)
AT (1) ATE181480T1 (es)
CA (1) CA2214713C (es)
DE (1) DE69603016T2 (es)
DK (1) DK0814660T3 (es)
ES (1) ES2134608T3 (es)
MX (1) MX9707203A (es)
WO (1) WO1996028975A1 (es)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6362009B1 (en) 1997-11-21 2002-03-26 Merck & Co., Inc. Solid phase synthesis of heterocycles
MY122454A (en) * 1998-06-05 2006-04-29 Upjohn Co Use of oxazolidinones for the preparation of a medicament for transdermal delivery
US6319958B1 (en) 1998-06-22 2001-11-20 Wisconsin Alumni Research Foundation Method of sensitizing microbial cells to antimicrobial compound
US6071955A (en) * 1999-02-25 2000-06-06 The Regents Of The University Of California FXR, PPARA and LXRA activators to treat acne/acneiform conditions
US6489456B1 (en) * 2000-10-27 2002-12-03 Pe Corporation (Ny) Isolated human secreted proteins, nucleic acid molecules encoding human secreted proteins, and uses thereof
CA2450073C (en) 2001-07-25 2017-08-29 Biomarin Pharmaceutical Inc. Compositions and methods for modulating blood-brain barrier transport
US20040057908A1 (en) * 2001-12-13 2004-03-25 Bowen William H. Oral compositions and use thereof
US6921489B2 (en) * 2002-07-19 2005-07-26 Orris E. Albertson Aerated grit chamber and method
US7037535B2 (en) 2002-11-19 2006-05-02 Kimberly-Clark Worldwide, Inc. Method and composition for neutralizing house dust mite feces
US20050019379A1 (en) 2003-07-22 2005-01-27 Kimberly-Clark Worldwide, Inc. Wipe and methods for improving skin health
US8110215B2 (en) * 2004-04-30 2012-02-07 Kimberly-Clark Worldwide, Inc. Personal care products and methods for inhibiting the adherence of flora to skin
CA2570245A1 (en) * 2004-07-02 2006-01-12 Warner-Lambert Company Llc Compositions and methods for treating pathological infections
EP2671508B1 (en) 2005-04-28 2020-09-16 Proteus Digital Health, Inc. Pharma-informatics system
US20060263440A1 (en) * 2005-05-19 2006-11-23 Cecil Jackie J Acne treatment
JP2010503710A (ja) 2006-09-18 2010-02-04 ラプトール ファーマシューティカル インコーポレイテッド 受容体関連タンパク質（ｒａｐ）結合体の投与による肝障害の処置
GB2453807A (en) * 2007-10-15 2009-04-22 Botan Century Purified tanshinone extracts from Salvia spp and their antibacterial effects
ES2919563T3 (es) 2009-02-20 2022-07-27 Enhanx Biopharm Inc Sistema de administración de medicamentos a base de glutatión
KR20180114970A (ko) 2009-05-06 2018-10-19 라보라토리 스킨 케어, 인크. 활성제-칼슘 포스페이트 입자 복합체를 포함하는 피부 전달 조성물 및 이들을 이용하는 방법
US20120077778A1 (en) 2010-09-29 2012-03-29 Andrea Bourdelais Ladder-Frame Polyether Conjugates

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4692329A (en) * 1980-12-08 1987-09-08 William H. Rorer, Inc. Erythromycin/benzoyl peroxide antiacne compositions
US4896768A (en) * 1986-10-06 1990-01-30 Lab Products, Inc. Anti-bacterial and anti-viral presaturated wipe product

Also Published As

Publication number Publication date
DE69603016T2 (de) 1999-10-21
US5610196A (en) 1997-03-11
JP3055701B2 (ja) 2000-06-26
ATE181480T1 (de) 1999-07-15
WO1996028975A1 (en) 1996-09-26
DE69603016D1 (de) 1999-07-29
EP0814660A1 (en) 1998-01-07
JPH10510291A (ja) 1998-10-06
DK0814660T3 (da) 1999-11-22
CA2214713C (en) 2001-07-31
MX9707203A (es) 1998-03-31
EP0814660B1 (en) 1999-06-23
CA2214713A1 (en) 1996-09-26
US5604262A (en) 1997-02-18

Similar Documents

Publication Publication Date Title
PA8486001A1 (es) Composiciones de celecoxib
ES2171416T3 (es) Remedio contra la trombocitopenia.
ES2172303T3 (es) Agentes terapeuticos obtenidos por catalisis enzimatica.
DK0814660T3 (da) Topiske, antimikrobielle midler
GT199900198A (es) Azalidas de 13 miembros y su uso como agentes antibioticos.
FR2729147B1 (es)
GT199900208A (es) Antibiòticos cetòlidos carbamato y carbazato.
AR020660A1 (es) Composiciones antibioticas para el tratamiento de ojos, oidos y nariz
AR029544A1 (es) Composiciones y metodos para tratar infecciones bacterianas
BR0015177A (pt) ésteres de ácido benzóico de oxazolidinonas possuindo um substituinte hidroxiacetilpiperazina
ES2116634T3 (es) Nuevo empleo de 1alfa-fluoro-25-hidroxi-16-en-23-in-colecalciferol.
AR025379A1 (es) 9a-azalidas con actividad antibacteriana.
TR199800634T1 (xx) Strobilurin Analog Bile�i�i ��eren Sinerjistik Mantar �ld�r�c� Kompozisyon.
ES2191763T3 (es) Inhibidor del desarrollo de dependencia/tolerancia a un agente analgesico narcotico.
BR9712926A (pt) Sabão anti-séptico em barra
ES2173586T3 (es) Derivados de ciclohexandiol.
GT200000105A (es) Sal difosfato de un derivado de 4" - sustituido - 9 - desoxo - 9a - aza - 9a - homoeritromicina y sucomposicion farmaceutica.
ES2196171T3 (es) Agentes antitumorales de tioxantenona liofilizada.
DE69430074D1 (de) Analgetische 4-arylisoindolen
BR0316245A (pt) Atividade antimicrobiana de espécie de oxigênio reativo produtora de anticorpos
ES2177623T3 (es) Composiciones farmaceuticas que contienen ceftriaxona y penems.
BR9915292A (pt) Associação, utilização de riluzol e composição farmacêutica.
DK0763976T3 (da) Fungicide blandinger
DK0669826T3 (da) (-)-Metrifonatholdigt lægemiddel
AR005866A1 (es) Composicion farmaceutica antioxidante

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 814660

Country of ref document: ES